PTC Therapeutics (NASDAQ: PTCT) reported fourth-quarter results that missed Wall Street expectations on both earnings and revenue, even as management pointed to strong momentum from the recent launch ...

PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the fourth quarter and full year ending December 31, 2025.

Cincinnati natural gas rates surged 122% as Duke Energy Ohio raised its February PTC rate after Winter Storm Fern. Shop ...

This verdict could spell the end for Translarna’s decades-long and tumultuous US DMD development journey.

Akron natural gas rates surged 53% as Enbridge Gas Ohio raised its February PTC to $7.96 per MCF. Shop fixed-rate plans ...

Honorees recognized at PTC’s largest annual conference in its 48 year history Each recipient is contributing in ...

HONOLULU, HI, UNITED STATES, January 29, 2026 /EINPresswire.com/ -- PTC, a global non profit advancing digital ...

ISLAMABAD: The Pakistan Textile Council (PTC) has urged Prime Minister Shehbaz Sharif to reconsider the off-grid (cogeneration) levy framework and advance genuine gas market reform through neutral ...

PTC Therapeutics Inc. reports fourth-quarter earnings after the market close Thursday, with investors eager to assess whether the company’s newly launched PKU treatment can offset a recent regulatory ...

PTC (NasdaqGS:PTC) has been selected by SPG Company to provide its FlexPLM solution. SPG Company is replacing its legacy ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna.  | Late Thursday, PTC revealed that ...

PTC Therapeutics announced it will withdraw the ataluren NDA for nmDMD, citing FDA concerns regarding the evidence of the agent's effectiveness.